August 3, 2026 – Therapy with DNA repair inhibitors in early phase clinical trials

There has been no significant differences in HbA1c levels or severe hypoglycaemia events between two organizations, with both organizations achieving a comparable HbA1c reduction relative

Day: August 3, 2026

Imputations for missing data were based on the median distance traveled for the patients with data, stratified by residence (outside or inside Kushiro)

There has been no significant differences in HbA1c levels or severe hypoglycaemia events between two organizations, with both organizations achieving a comparable HbA1c reduction relative to baseline

Day: August 3, 2026

﻿Imputations for missing data were based on the median distance traveled for the patients with data, stratified by residence (outside or inside Kushiro)

﻿There has been no significant differences in HbA1c levels or severe hypoglycaemia events between two organizations, with both organizations achieving a comparable HbA1c reduction relative to baseline

Imputations for missing data were based on the median distance traveled for the patients with data, stratified by residence (outside or inside Kushiro)

There has been no significant differences in HbA1c levels or severe hypoglycaemia events between two organizations, with both organizations achieving a comparable HbA1c reduction relative to baseline